Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.96 USD | +4.64% | +12.17% | +134.48% |
03-14 | VTv Therapeutics Inc. Announces Board Changes | CI |
03-13 | VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 2.02M 161M | Sales 2023 | - | Capitalization | 23.43M 1.87B |
---|---|---|---|---|---|
Net income 2022 | -19M -1.52B | Net income 2023 | -20M -1.6B | EV / Sales 2022 | 21.1 x |
Net cash position 2022 | 11.42M 912M | Net cash position 2023 | 8.98M 717M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.59
x | P/E ratio 2023 |
-1.18
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.63% |
1 day | +4.64% | ||
1 week | +12.17% | ||
Current month | +14.60% | ||
1 month | +14.60% | ||
3 months | +226.85% | ||
6 months | +55.76% | ||
Current year | +134.48% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CEO | Chief Executive Officer | 66 | 31/07/22 |
Steven Tuch
DFI | Director of Finance/CFO | 56 | 07/12/22 |
Vanessa McDade
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 02-26 | |
Paul Sekhri
CEO | Chief Executive Officer | 66 | 31/07/22 |
Richard Nelson
BRD | Director/Board Member | 54 | 15/11/20 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 26.96 | +4.64% | 3,777 |
25/04/24 | 25.77 | +1.06% | 1,576 |
24/04/24 | 25.5 | +2.10% | 5,602 |
23/04/24 | 24.98 | +2.21% | 4,442 |
22/04/24 | 24.44 | +1.64% | 2,994 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+134.48% | 65.6M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VTVT Stock